Matches in Nanopublications for { ?s ?p "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403834.RAkugUxqz9veegDBVVYyRYTxFEtZFmz5PX8NlHWhHv84w130_provenance.
- assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP690776.RAAlGNVlMje9ZYh9KVWXcT5AQwYYBzDv4ePMVJwEEpjxU130_assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690776.RAAlGNVlMje9ZYh9KVWXcT5AQwYYBzDv4ePMVJwEEpjxU130_provenance.
- NP435569.RAk7aNgJ587cHr2oxeatByvFHTU4VPeW0apDcTshfL2TI130_assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435569.RAk7aNgJ587cHr2oxeatByvFHTU4VPeW0apDcTshfL2TI130_provenance.
- NP435586.RAr8Tj5LjqSnzCNjbPYmwxPeTeilbdMmHBETyJ9eIPzd8130_assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435586.RAr8Tj5LjqSnzCNjbPYmwxPeTeilbdMmHBETyJ9eIPzd8130_provenance.
- NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_provenance.